Health spending projections through 2019: the recession's impact continues
- PMID: 20133357
- DOI: 10.1377/hlthaff.2009.1074
Health spending projections through 2019: the recession's impact continues
Abstract
The economic recession and rising unemployment-plus changing demographics and baby boomers aging into Medicare-are among the factors expected to influence health spending during 2009-2019. In 2009 the health share of gross domestic product (GDP) is expected to have increased 1.1 percentage points to 17.3 percent-the largest single-year increase since 1960. Average public spending growth rates for hospital, physician and clinical services, and prescription drugs are expected to exceed private spending growth in the first four years of the projections. As a result, public spending is projected to account for more than half of all U.S. health care spending by 2012.
Similar articles
-
Health spending projections through 2018: recession effects add uncertainty to the outlook.Health Aff (Millwood). 2009 Mar-Apr;28(2):w346-57. doi: 10.1377/hlthaff.28.2.w346. Epub 2009 Feb 24. Health Aff (Millwood). 2009. PMID: 19240055
-
Health spending projections through 2013.Health Aff (Millwood). 2004 Jan-Jun;Suppl Web Exclusives:W4-79-93. doi: 10.1377/hlthaff.w4.79. Health Aff (Millwood). 2004. PMID: 15451969
-
Health spending projections through 2017: the baby-boom generation is coming to Medicare.Health Aff (Millwood). 2008 Mar-Apr;27(2):w145-55. doi: 10.1377/hlthaff.27.2.w145. Epub 2008 Feb 26. Health Aff (Millwood). 2008. PMID: 18303038
-
Health spending projections through 2016: modest changes obscure part D's impact.Health Aff (Millwood). 2007 Mar-Apr;26(2):w242-53. doi: 10.1377/hlthaff.26.2.w242. Epub 2007 Feb 21. Health Aff (Millwood). 2007. PMID: 17314105 Review.
-
Issues in health care: interventional pain management at the crossroads.Pain Physician. 2007 Mar;10(2):261-84. Pain Physician. 2007. PMID: 17387349 Review.
Cited by
-
The intriguing future of pharmacoepidemiology.Eur J Clin Pharmacol. 2013 May;69 Suppl 1:43-51. doi: 10.1007/s00228-013-1496-6. Epub 2013 May 3. Eur J Clin Pharmacol. 2013. PMID: 23640187
-
Reducing potentially avoidable complications in patients with chronic diseases: the Prometheus Payment approach.Health Serv Res. 2010 Dec;45(6 Pt 2):1854-71. doi: 10.1111/j.1475-6773.2010.01136.x. Health Serv Res. 2010. PMID: 20662949 Free PMC article.
-
Cost implications of the rapid adoption of newer technologies for treating prostate cancer.J Clin Oncol. 2011 Apr 20;29(12):1517-24. doi: 10.1200/JCO.2010.31.1217. Epub 2011 Mar 14. J Clin Oncol. 2011. PMID: 21402604 Free PMC article.
-
Accuracy of annual prescription drug expenditure forecasts in AJHP.Am J Health Syst Pharm. 2015 Oct 1;72(19):1642-8. doi: 10.2146/ajhp140850. Am J Health Syst Pharm. 2015. PMID: 26386105 Free PMC article.
-
Evolution of costs of cancer drugs in a Portuguese hospital.World J Clin Oncol. 2014 May 10;5(2):164-9. doi: 10.5306/wjco.v5.i2.164. World J Clin Oncol. 2014. PMID: 24829864 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials